By Jamie Martin
The National Institutes of Health (NIH) is actively monitoring the H5N1 avian influenza virus, emphasizing the need for a balanced approach between heightened vigilance and maintaining routine activities.
According to NIH experts, the risk to the general public remains low, and existing treatments and vaccines are effective against current strains.
Dr. Jeanne M. Marrazzo and Dr. Michael G. Ison from the National Institute of Allergy and Infectious Diseases (NIAID) highlighted the importance of collaboration among health professionals across various sectors to manage the threat effectively. They also noted the critical role of disease surveillance in detecting mutations that could influence the virus's ability to infect humans.
The recent spread of H5N1 across continents and its detection in different animal species in the U.S. underlines the need for ongoing vigilance. The virus has shown the capacity to infect not only birds but also mammals, including dairy cows, increasing the complexity of managing its spread and potential mutation.
Effective disease management strategies, as outlined by NIH officials, include continued development and testing of vaccines and antiviral drugs, alongside education and the use of personal protective equipment by those in high-risk occupations, such as poultry and dairy workers.
NIH and its partners remain dedicated to providing the public and healthcare providers with the information and tools necessary to prevent and respond to H5N1, ensuring the safety and health of both the population and the agricultural community. For more detailed information, please visit www.nih.gov.
Photo Credit: usda
Categories: National